US Patent 10526417 Heterodimeric antibodies that bind CD3 and CD38
Patent 10526417 was granted and assigned to Xencor on January, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10526417 Heterodimeric antibodies that bind CD3 and CD38
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.